United Therapeutics Corp (NASDAQ:UTHR)

155.05
Delayed Data
As of Feb 27
 -0.53 / -0.34%
Today’s Change
84.63
Today|||52-Week Range
164.38
+19.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues743.2M914.1M1.1B1.3B
 
 
 
 
 
Cost of Goods Sold68.4M92.2M99.9M125.9M
 
 
 
 
 
Depreciation And Amortization20.5M27.1M31.3M--
 
 
 
 
 
Operating ExpensesGross Income654.3M794.8M985.9M1.2B
 
 
 
 
 
General Expenses344.2M368.3M693.4M623.8M
 
 
 
 
 
Research And Development180.0M173.4M299.3M242.5M
 
 
 
 
 
Total Operating Expenses433.1M487.6M824.5M749.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income310.1M426.4M292.5M538.8M
 
 
 
 
 
Extraordinary Credit0.0033.0M210.0K--
 
 
 
Extraordinary Charge0.00-6.8M0.00--
 
 
Pre-Tax Equity Earnings-119.0K-143.0K0.00--
 
 
 
Interest Expense On Debt22.2M17.5M18.1M17.6M
 
 
 
 
 
Other Expenses7.1M866.0K425.0K4.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income299.1M440.7M278.9M525.2M
 
 
 
 
 
Income Taxes-81.9M-136.2M-104.3M-185.1M
 
 
 
 
 
Discontinued Operations7.0K0.000.00--
 
 
Extraordinary Items618.0K0.000.00--
 
 
Net Income217.3M304.4M174.6M340.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS57.2M52.1M50.1M48.2M
 
 
 
 
 
Shares To Calculate EPS Diluted59.4M53.3M53.2M54.2M
 
 
 
 
 
 
Earnings Per ShareEPS$3.67$5.71$3.28$6.28
 
 
 
 
 
EPS Diluted$3.66$5.71$3.28$6.28
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account